Balchem Corporation (BCPC)
$
166
+2.21 (1.33%)
Key metrics
Financial statements
Free cash flow per share
4.4961
Market cap
5.5 Billion
Price to sales ratio
5.7214
Debt to equity
0.0296
Current ratio
1.9899
Income quality
1.4166
Average inventory
124.7 Million
ROE
0.1137
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products catering to diverse sectors, including nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets both in the United States and internationally. The company reported a notable revenue of $953,684,000.00 showcasing its steady growth during the fiscal year 2024. It incurred an income tax expense of $37,978,000.00 indicating its tax obligations in line with its pre-tax profitability, as demonstrated by an income before tax of $166,453,000.00. Additionally, Balchem earned an interest income of $0.00 showcasing its engagement in financial investments. The company's operations span three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment serves the food and beverage industry with a range of products, including spray dried and emulsified powders, blended lipid systems, and microencapsulation solutions. Meanwhile, the Animal Nutrition & Health segment enhances health and milk production with microencapsulated products and choline chloride for monogastric animal health. The Specialty Products segment focuses on ethylene oxide for healthcare applications and also markets propylene oxide as a fumigant for controlling spoilage in various food products. In the context of market performance, the stock is reasonably priced at $163.68 appealing to a broad range of investors. Despite this appeal, the stock has a low average trading volume of 154,898.00 suggesting lower market activity and potential limits on liquidity. With a mid-range market capitalization of $5,400,428,200.00 the company remains a steady performer in the financial landscape. It is a key player in the Chemicals - Specialty industry, contributing significantly to the overall market landscape and enhancing its relevance. Balchem belongs to the Basic Materials sector, where it continues to drive innovation and growth through its commitment to quality and excellence in specialty performance ingredients and products.
Analysts predict Balchem Corporation stock to fluctuate between $137.69 (low) and $186.03 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-04-01, Balchem Corporation's market cap is $5,400,428,200, based on 32,532,700 outstanding shares.
Compared to The Sherwin-Williams Company, Balchem Corporation has a Lower Market-Cap, indicating a difference in performance.
To buy Balchem Corporation (BCPC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for BCPC. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Revenue: $953,684,000 | EPS: $3.97 | Growth: 17.46%.
Visit https://www.balchem.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $186.03 (2024-07-29) | All-time low: $106.29 (2021-02-01).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
Balchem Corporation (NASDAQ:BCPC ) Q4 2024 Earnings Conference Call February 21, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call Participants Bob Labick - CJS Securities Ram Selvaraju - H.C. Wainwright & Co Daniel Harriman - Sidoti & Company Operator Greetings, and welcome to Balchem's Fourth Quarter and Full Year 2024 Earnings Call.
zacks.com
Blachem (BCPC) came out with quarterly earnings of $1.03 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.82 per share a year ago.
globenewswire.com
MONTVALE, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 21, 2025, at 11:00 AM Eastern Time (ET) to review fourth quarter and full year 2024 results.
globenewswire.com
MONTVALE, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at CJS Securities New Ideas for the New Year Virtual Conference on January 14, 2025.
marketbeat.com
The chemicals industry—companies creating chemicals used in industrial, commercial, and a variety of other applications—thrived for many years leading up to and including the COVID-19 pandemic. However, a recent report by McKinsey & Co. shows that the period since the end of the pandemic has brought a sharp reversal of this trend, with chemicals companies as a group achieving growth of under 2% per year since late 2022 while global indexes have increased 24% per year over the same period.
zacks.com
Here is how Blachem (BCPC) and Fresnillo PLC (FNLPF) have performed compared to their sector so far this year.
zacks.com
Blachem (BCPC) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
globenewswire.com
MONTVALE, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that on December 9, 2024, its Board of Directors declared a dividend on its shares of common stock equal to $0.87 per share on the Company's issued and outstanding Common Stock, to be payable on January 17, 2025 to stockholders of record at the close of business on December 26, 2024.
zacks.com
Here is how Blachem (BCPC) and MAG Silver (MAG) have performed compared to their sector so far this year.
zacks.com
Blachem (BCPC) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
See all news